See other bills
under the
same topic
        PRIOR PRINTER'S NO. 901                       PRINTER'S NO. 1581

THE GENERAL ASSEMBLY OF PENNSYLVANIA


SENATE BILL

No. 778 Session of 2007


        INTRODUCED BY ARMSTRONG, ORIE, RAFFERTY, FERLO, COSTA, EARLL,
           RHOADES, WAUGH, MADIGAN, STOUT, WONDERLING, STACK AND
           BRUBAKER, APRIL 27, 2007

        SENATOR ARMSTRONG, APPROPRIATIONS, RE-REPORTED AS AMENDED,
           NOVEMBER 27, 2007

                                     AN ACT

     1  Providing for long-term care patient access to pharmaceuticals;
     2     and conferring powers and duties on the State Board of
     3     Pharmacy.

     4     The General Assembly of the Commonwealth of Pennsylvania
     5  hereby enacts as follows:
     6  Section 1. Short title.
     7     This act shall be known and may be cited as the Long-Term
     8  Care Patient Access to Pharmaceuticals Act.
     9  Section 2.  Legislative intent.
    10     The General Assembly finds and declares as follows:
    11         (1)  A mechanism is to be provided whereby patients who
    12     have the ability to acquire lower cost drugs through the
    13     Veterans' Administration have access to those drugs if they
    14     reside in a long-term care facility.
    15         (2)  The mechanism is to be provided by permitting the
    16     pharmacy within the long-term care facility or which has a
    17     contract with the long-term care facility to:


     1             (i)  receive the lower cost drugs directly from the
     2         Veterans' Administration drug benefit program in the
     3         patient's name; and
     4             (ii)  repackage and relabel those drugs so they may
     5         be dispensed in unit doses in compliance with the Food
     6         and Drug Administration, the United States Pharmacopeia
     7         and the long-term care facility's policies and procedures
     8         to patients in a long-term care facility.
     9         (3)  This act shall be interpreted and construed to
    10     effectuate the following purposes:
    11             (i)  To provide for the care, protection and
    12         treatment of patients in long-term care facilities by
    13         allowing them to utilize the drug benefit provided by the
    14         Veterans' Administration.
    15             (ii)  Consistent with the care, protection and
    16         treatment of patients in long-term care facilities, to
    17         provide a means by which a pharmacy in a long-term care
    18         facility or a pharmacy which has a contract with a long-
    19         term care facility may:
    20                 (A)  accept, on behalf of the patient, drugs
    21             received directly from the Veterans' Administration;
    22             and
    23                 (B)  repackage and relabel those drugs so that
    24             the patient may receive them in a unit dose in
    25             compliance with the Food and Drug Administration, the
    26             United States Pharmacopeia and the long-term care
    27             facility's policies and procedures.
    28             (iii)  To provide a means through which the
    29         provisions of this act are executed and enforced and in
    30         which long-term care facilities, pharmacists, drug source
    20070S0778B1581                  - 2 -     

     1         facilities and pharmaceutical providers may implement the
     2         provisions of this act.
     3         (4)  ONLY INDIVIDUALS ELIGIBLE FOR BENEFITS PROVIDED BY    <--
     4     THE VETERANS' ADMINISTRATION ARE ELIGIBLE FOR THE PROGRAM
     5     UNDER THIS ACT.
     6  Section 3.  Definitions.
     7     The following words and phrases when used in this act shall
     8  have the meanings given to them in this section unless the
     9  context clearly indicates otherwise:
    10     "Board."  The State Board of Pharmacy.
    11     "Drug source facility."  A facility where drugs are lawfully   <--
    12  manufactured, dispensed or distributed. The term includes a
    13     "DRUG SOURCE FACILITY."  A FACILITY:                           <--
    14         (1)  WHERE DRUGS ARE LAWFULLY MANUFACTURED, DISPENSED OR
    15     DISTRIBUTED; AND
    16         (2)  WHICH IS:
    17             (I)  OPERATED BY OR UNDER CONTRACT WITH THE VETERANS'
    18         ADMINISTRATION; OR
    19             (II)  APPROVED BY THE VETERANS' ADMINISTRATION.
    20  THE TERM INCLUDES A pharmacy, an entity and a Federal or State
    21  agency or instrumentality.
    22     "Long-term care facility."  A long-term care nursing facility
    23  as defined in section 802.1 of the act of July 19, 1979
    24  (P.L.130, No.48), known as the Health Care Facilities Act.
    25     "Pharmaceutical provider."  An entity that employs a
    26  pharmacist.
    27  Section 4.  State Board of Pharmacy.
    28     The board has the following powers and duties:
    29         (1)  Develop the form required by section 5(b)(3) and
    30     (4).
    20070S0778B1581                  - 3 -     

     1         (2)  Publish a notice in the Pennsylvania Bulletin that
     2     the form has been developed.
     3  Section 5.  Third-party drugs in long-term care facilities.
     4     (a)  Authority.--Notwithstanding any other provision of law,
     5  all of the following may dispense a drug acquired from a drug
     6  source facility outside the long-term care facility to a patient
     7  of a long-term care facility:
     8         (1)  A pharmacist employed by a long-term care facility.
     9         (2)  A pharmacy who contracts with a long-term care
    10     facility to fill prescriptions for patients of the long-term
    11     care facility.
    12     (b)  Unit dose.--A person authorized under subsection (a) to
    13  dispense a drug shall repackage, relabel and dispense the drug
    14  in a unit dose if all of the following conditions are met:
    15         (1)  The drug is obtained from a drug source facility.
    16         (2)  There is a prescription for the drug.
    17         (3)  The prescriber has signed a form authorizing the
    18     long-term care facility to administer a drug from a drug
    19     source facility outside the long-term care facility.
    20         (4)  The patient has signed a form authorizing the long-
    21     term care facility to administer a drug from a drug source
    22     facility outside the long-term care facility and provided
    23     payment information for payment of the related fees to the
    24     pharmacy. In the case of a minor or a patient who is unable
    25     to sign the form, a parent, a guardian, an agent acting under
    26     a power of attorney or a family member is authorized to sign
    27     the form. The form must explain that a person authorized
    28     under subsection (a) to dispense a drug from a drug source
    29     facility outside the long-term care facility:
    30             (i)  is required to go through the process of
    20070S0778B1581                  - 4 -     

     1         repackaging and relabeling the drug;
     2             (ii)  may charge a fee for repackaging and relabeling
     3         the drug, including the amount of the fee and the
     4         frequency of its assessment; and
     5             (iii)  has immunity from civil liability arising from
     6         dispensation of the drug if the person properly
     7         repackages and relabels the drug as set forth in section
     8         8.
     9         (5)  The nursing facility attending physician has issued
    10     an order continuing the patient's medical regime.
    11         (6)  The drug is not a controlled substance.
    12         (7)  The repackaging is in compliance with the Food and
    13     Drug Administration, the United States Pharmacopeia and the
    14     long-term care facility's policies and procedures.
    15         (8)  The Veterans' Administration provides the drug
    16     directly to the long-term care pharmacy in the patient's name
    17     and with the following information in preparation for the
    18     repackaging and relabeling:
    19             (i)  The name and address of the dispensing pharmacy.
    20             (ii)  The name of the dispensing pharmacist.
    21             (iii)  The lot number of the drug.
    22             (iv)  A copy of the original prescription.
    23             (v)  The date the drug was dispensed.
    24             (vi)  Directions for use, contraindications and other
    25         materials required by law to be provided to the patient.
    26  Section 6.  Recordkeeping.
    27     For each drug dispensed in accordance with section 5(a), the
    28  person authorized to dispense the drug and the long-term care
    29  facility shall maintain a record for at least two years of all
    30  of the items specified in section 5(b)(8).
    20070S0778B1581                  - 5 -     

     1  Section 7.  Fee.
     2     A person authorized under 5(a) to dispense a drug may charge
     3  a reasonable fee to repackage and relabel the drug. Fees so
     4  charged shall not exceed:
     5         (1)  $20 for up to 90 units per drug;
     6         (2)  $10 additional for half tablets; and
     7         (3)  $10 for each additional 90 units.
     8  Section 8.  Civil liability and unprofessional conduct.
     9     (a)  Repackaging and relabeling.--A person authorized under
    10  section 5(a) to dispense a drug shall be immune from civil
    11  liability arising out of dispensation of the drug if the person
    12  properly repackages and relabels a drug based on the information
    13  received from the original drug source facility.
    14     (b)  Administration of drug.--A long-term care facility or an
    15  employee or agent of a long-term care facility that properly
    16  administers a drug from a person authorized under section 5(a)
    17  to dispense the drug shall be immune from civil liability
    18  arising out of administration of the drug.
    19     (c)  Unprofessional conduct.--A pharmacist authorized under
    20  section 5(a) to dispense a drug who properly relabels and
    21  repackages the drug shall not be deemed to have engaged in
    22  unprofessional conduct under section 5 of the act of September
    23  27, 1961 (P.L.1700, No.699), known as the Pharmacy Act.
    24  Section 40.  Effective date.
    25     This act shall take effect 90 days following the publication
    26  of the notice in the Pennsylvania Bulletin required under
    27  section 4(2).


    A16L35JLW/20070S0778B1581        - 6 -